In Congresswoman Anna G. Eshoo’s two decades in Congress, she has defended consumers, promoted American competitiveness and innovation, fought for access to health care for families and children, protected the environment, and encouraged development of clean energy technology. More recently, the House of Representatives passed her Advanced Research Projects Agency-Health (ARPA-H) Act to create an independent health agency “to cure and treat the world’s deadliest diseases.”

Dr. Diana Ramos is the Surgeon General of California. Prior to this role, she was director of state public health and prevention programs at the California Department of Public Health’s Center for Healthy Communities and before that she spent four years as CDPH’s public health medical officer.

Byron Katie is an American speaker and author who teaches a method of self-inquiry known as “The Work of Byron Katie.” She is the founder of Byron Katie International, an organization that includes the School for the Work and Turnaround House in Ojai, California. Time magazine describes her as “a spiritual innovator for the 21st century.”

Nichol Bradford is fascinated by human potential and technology. She is the CEO & Founder of the Willow Group and the Executive Director and co-founder of the Transformative Technology Lab, Conference, and TT200 List. Prior to becoming a leader in Transformative Technology, Bradford was a senior executive in video games with responsibility for strategy, operations and marketing for major brands that include: Activision Blizzard, Disney, and Vivendi Games — including operating World of Warcraft China.

Dr. Mishra is trained in the computational, cognitive and translational neurosciences. She is the founder of the Neural Engineering & Translation Labs (NEATLabs) at UCSD. Her lab innovates digital technologies for scalable brain health mapping, monitoring and precision therapeutics. Dr. Mishra’s interdisciplinary research interests are at the intersection of neuroscience and digital engineering, integrating machine learning methods to personalize and inform mental healthcare, education, and climate change adaptation efforts.

Daniel Kraft is a Harvard-trained physician-scientist, inventor, entrepreneur, and innovator and is serving as the Chair of the XPRIZE Pandemic &Health Alliance Task Force. With over 25 years of experience in clinical practice, biomedical research and healthcare innovation, Kraft has served as faculty chair for Medicine at Singularity University since its inception in 2008, and is founder and chair of Exponential Medicine. 6x TedX and TEDMED speaker. Voted Digital Health Top 50.

Within her Center, Dr. Williams’ leads the PanLab for Precision Psychiatry and Translational Neuroscience. The PanLab has developed a radical new way to understand and treat mental health disorders based on a personalized approach to neuroscience. Dr. Williams also leads department-wide initiatives in precision mental health as Associate Chair of Translational Neuroscience. She has a joint position at the Palo Alto VA Mental Illness Research, Education and Clinical Center where she is Director of Education and Precision Medicine.

Danny Gladden, MBA, MSW, LCSW, is General Manager and Director of Behavioral Health and Social Care for Oracle Health with responsibility for Oracle Cerner’s behavioral health and social care solutions. A licensed clinical social worker, former community BH & SUD practice COO and a practicing mental health and SUD treatment clinician, Danny champions real time, barrier free access to mental health and SUD treatment services with a particular focus working with consumers at risk of suicide and those living with severe and persistent mental illness.  Danny previously served as clinical leader of a National Suicide Prevention and Veterans crisis contact center and is an Adjunct Clinical Professor of Social Work at St. Louis University School of Social Work.

Ruth O’Hara, PhD, is the Lowell W. and Josephine Q. Berry Professor at Stanford and is the Director of Stanford Center for Clinical and Translational Research and Education (SPECTRUM), as well as the Senior Associate dean of Research at the Stanford School of Medicine. In 2021, she was elected as Chair of the Faculty Senate.

Ariel B. Ganz, PhD is a postdoctoral fellow at Stanford University in the Snyder Lab. Her research gives an academic lens to popular wellness practices to reveal clinically promising effective strategies for depression and well-being. She is a founding partner at Arben Ventures, investing in early-stage companies with global impact.

After a career in talent management & tech innovation, Ben realized that his true passion lies in Salutogenic Medicine —the medicine of health and thriving. As the Director of Stanford’s Healthcare Innovation Lab, Ben has a mission to fix the broken healthcare system. He is leading an effort with Stanford scientists to bridge the gap between technology and medicine. Their goal is to transition the world from healthcare 1.5 to healthcare 2.0 by providing breakthrough innovations that make personalized, precision healthcare an affordable reality for all people across the globe. He is also a founding partner at Arben Ventures.

Dr Rosalind Watts is a clinical psychologist and the founder of ACER Integration. Her contributions to the field of psychedelic therapy are numerous and include the development of the the ACE model ‘Accept, Connect, Embody’, which has been used in clinical trials of both psilocybin and DMT, as well as the Watts Connectedness Scale, which is a psychometric tool for measuring outcomes of psychedelic therapy. Dr Watts is the former clinical lead on the Psilocybin for Depression trial at Imperial College London, the clinical track lead on the Synthesis Institute’s psychedelic practitioner training, and sits on the clinical advisory board of the Usona Institute.

Yuriy Blokhin is Founder and CEO at Homecoming, a digital integration platform for clinicians and therapists to use with their patients. Yuri was the first employee at the Canadian tech company Kik, where he helped create and design a cognitive therapy chatbot for teens. Additionally, Yuri is a founding member of the Heroic Hearts Project, a non-profit organization that connects traumatized veterans with psychedelic therapy.

Antoun Nabhan, JD, is a biotech and medical device investor and executive. He is former VP of Pear Therapeutics, CFO of Establishment Labs, and VP of Corporate Development at Sagamore Bioventures.

Lauren works at the Tony Blair Institute for Global Change, where she focuses on science and innovation policy. Previously, she worked as a climate change litigator at the Center for Biological Diversity and for the California Department of Justice. She also serves on the board of the Robert Packard Center for ALS Research at Johns Hopkins.

Jess is based at the Tony Blair Institute for Global Change, where she supports leaders in understanding and responding to the next generation of emerging technologies. She previously worked with some of the UK’s leading businesses and Her Majesty’s Government to improve productivity across the UK economy. She has served as a fellow at Harvard University’s Project on Workforce, and has been part of international teaching teams for leadership, ethics, and negotiation.

Jeffrey Becker, MD, trained at UCLA/NPI in both Medicine and Psychiatry with a focus on Neuropsychiatry and Functional Medicine. He is board-certified by the American Board of Psychiatry and Neurology as well as the American Board for Integrative and Holistic Medicine. He maintains clinical offices in Santa Barbara and Westwood and is affiliated with UCLA/NPI as Volunteer Clinical Faculty. He is a leading expert on Ketamine Therapy and is the Founder and CSO of Bexson Biomedical.